Moors & Cabot, Inc. Qiagen N.V. Transaction History

Moors & Cabot, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$35.55 - $43.57 $959 - $1,176	27 Added 0.03%	88,657 $3.85 Million
Q2 2023 Aug 09, 2023	BUY	$43.93 - $46.76 $1,273 - $1,356	29 Added 0.03%	88,630 $3.99 Million
Q3 2021 Dec 08, 2021	BUY	$46.55 - $56.83 $2.5 Million - $3.05 Million	53,669 Added 153.64%	88,601 $4.58 Million
Q3 2021 Nov 05, 2021	SELL	$46.55 - $56.83 $144,025 - $175,832	-3,094 Reduced 8.14%	34,932 $3.86 Million
Q3 2020 Nov 09, 2020	BUY	$42.51 - $52.42 $1.62 Million - $1.99 Million	38,026 New	38,026 $1.99 Million

Q2 2020 Aug 13, 2020	SELL	$39.49 - $44.36 $1.88 Million - $2.11 Million	-47,526 Closed	0 $0
Q4 2019 Jan 28, 2020	SELL	$25.41 - $43.1 $3,811 - $6,465	-150 Reduced 0.31%	47,526 $1.61 Million
Q1 2019 May 06, 2019	SELL	$33.78 - $40.68 $1.61 Million - $1.94 Million	-47,676 Reduced 50.0%	47,676 $1.94 Million
Q1 2019 May 01, 2019	BUY	$33.78 - $40.68 $2.83 Million - $3.41 Million	83,876 Added 730.88%	95,352 $3.88 Million
Q4 2018 Feb 13, 2019	BUY	$32.65 - $37.95 $6,530 - $7,590	200 Added 1.77%	11,476 $395,000
Q2 2018 Aug 14, 2018	BUY	$31.23 - $37.47 $352,149 - $422,511	11,276 New	11,276 $407,000

6.76M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $9.24B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

Stay updated on Moors & Cabot, Inc. with notifications on news.